| | Risks and management of dioxins and dioxin-like compounds in |
| | 5,41 | | MB | Baltic Sea fish: An integrated assessment |
| | 321 | | stron |
| | 5066 | | ID | University of Helsinki |
| | 2004 | | rok |
| | TABLE OF CONTENTS |
| | List of Figures and Tables |
| | Abbreviations |
| | Foreword |
| | Summary (Sammandrag, Yhteenveto) |
| | 1 Introduction |
| | 1.1 General background and historical importance of dioxin problems |
| | 1.2 Definitions and related methodological frameworks |
| | 1.2.1 Dioxins and dioxin-like compounds |
| | 1.2.2 Baltic Sea and related other areas |
| | 1.2.3 Risks and uncertainties |
| | 1.2.4 Risk assessment and risk management |
| | 1.3 Particular Baltic Sea fish relevance and issues |
| | 1.3.1 Dioxins in the Baltic Sea |
| | 1.3.2 Risk management by regulation of fish quality and fisheries |
| | 1.3.3 Defining policy-relevant risk and management analysis questions for Baltic Sea dioxins |
| | 1.3.4 The need for additional risk assessment and risk management analysis |
| | 1.4 Objectives and methodological approaches of the present work |
| | 1.4.1 Goals, objectives and scope |
| | 1.4.2 Approach and conduct |
| | 1.4.3 Structure of the report |
| | Part A: Risk assessment |
| | 2 Hazard and risk identification and framing: agents, influences and contexts |
| | 2.1 Conceptualization of risk chains and contexts, and approaches to decision-relevant risk |
| | identification |
| | 2.1.1 General considerations |
| | 2.1.2 Fish dioxin hazard and risk identification approaches |
| | 2.2 Dioxin-like compounds, their precursors and reaction products |
| | 2.2.1 Identification of dioxin-like compounds |
| | 2.2.2 Precursors and formation of dioxin-like compounds |
| | 2.3 Baltic Sea system compartments, processes and risk factors |
| | 2.3.1 System boundaries and interactions of the sea with land areas |
| | 2.3.2 Hydrography and ecology |
| | 2.3.3 Fishing, mariculture and other relevant technological processes |
| | 2.3.4 Dioxin fluxes to and from the sea |
| | 2.3.5 Processes affecting dioxin cycling and fate in the system |
| | 2.4 Dioxin receptors and risk groups in the Baltic Sea environment |
| | 2.4.1 Key organisms in food-chains accumulating dioxins |
| | 2.4.2 Particular risk groups |
| | 2.5 Fish consumption, other intakes and subsequent exposures |
| | 2.5.1 Exposure routes |
| | 2.5.2 Consumption of fish and other intakes of dioxins |
| | 2.5.3 From intakes to body burdens and internal exposures: Pharmacokinetics |
| | 2.6 Biological responses to dioxins and related stressors |
| | 2.6.1 Biochemical and biological basis of dioxin toxicity |
| | 2.6.2 Dimensions and continuums of responses |
| | 2.6.3 Effect profiles and receptor organisms |
| | 2.7 Compound-specific initial risk identification for in-depth assessment |
| | 2.8 Other risks and impacts of Baltic dioxins and fish, including indirect and social risks and |
| | benefits |
| | 2.8.1 General |
| | 2.8.2 Health benefits associated with fish |
| | 2.8.3 Other impacts |
| | 2.9 Summary of risk dimensions and assessment areas and levels |
| | 3 Exposure assessment |
| | 3.1 Assessment principles and evaluation of the quality of information |
| | 3.1.1 General considerations |
| | 3.1.2 Data and models |
| | 3.2 Sources and emissions of dioxins to the Baltic Sea |
| | 3.2.1 Polychlorodibenzo-p-dioxins and furans |
| | 3.2.2 Dioxin-like PCBs |
| | 3.2.3 Other dioxin-like compounds |
| | 3.3 Environmental transport and fate of dioxins in the Baltic Sea |
| | 3.3.1 Dioxin fluxes, cycling and transformation |
| | 3.3.2 Budgets of dioxins and dioxin-like PCBs in the Baltic Sea system |
| | 3.4 Environmental levels and trends, and body burdens in Baltic non-human receptors |
| | 3.4.1 Abiotic compartments |
| | 3.4.2 Biota |
| | 3.5 Human exposures to dioxins from the Baltic Sea as part of overall exposure |
| | 3.5.1 Consumption of fish and fish products and intakes of dioxins |
| | 3.5.2 Absorption, distribution, metabolism and excretion |
| | 3.5.3 Body burdens and contributions from fish |
| | 4 Effects assessment |
| | 4.1 Assessment principles and evaluation of the quality and relevance of information |
| | 4.1.1 General considerations |
| | 4.1.2 Weight of evidence and data quality |
| | 4.1.3 Approaches to effects assessment in the present work |
| | 4.2 Attributability of risks to causes and specification of the role of Baltic Sea fish dioxins |
| | 4.3 Effect types and levels, emphasizing human populations and experimental models |
| | 4.3.1 General considerations |
| | 4.3.2 Developmental and reproductive effects |
| | 4.3.3 Immune effects |
| | 4.3.4 Thyroid and other hormonal effects |
| | 4.3.5 Tumours and carcinogenic effects |
| | 4.3.6 Metabolic effects and other biological effects |
| | 4.3.7 Psychosomatic and non-biological effects in humans |
| | 4.3.8 Summarizing evaluation of human and experimental animal data |
| | 4.4 Dioxin-linked adverse effects in Baltic Sea dependent populations |
| | 4.4.1 General considerations and assessment approaches |
| | 4.4.2 Effects and effective exposure levels in Baltic Sea living and related species |
| | 4.4.3 Summarizing evaluation of dioxin-linked wildlife effects |
| | 4.5 Other biological effects of Baltic Sea fish, including beneficial health effects |
| | 4.5.1 Other adverse health effects of Baltic Sea fish |
| | 4.5.2 Health benefits from fish consumption |
| | 5 Risk and uncertainty characterization |
| | 5.1 Variations and qualities of risks associated with dioxins in Baltic Sea fish |
| | 5.1.1 Mixture effects and risks of various compounds |
| | 5.1.2 Variations and relations of risks among receptors |
| | 5.1.3 Temporal dimensions and variations of risks |
| | 5.1.4. Geographical dimensions and variations of risks |
| | 5.1.5 General qualities of effects and risks |
| | 5.2 Uncertainties of risks and benefits |
| | 5.2.1 Types, qualities and characteristics of uncertainties in risks and benefits |
| | 5.2.2 Quantification of uncertainties |
| | 5.3 Risk-risk and risk-benefit comparisons |
| | 5.3.1 General considerations |
| | 5.3.2 Risk-risk comparisons |
| | 5.3.3 Risks and benefits from human consumption of fatty sea fish |
| | 5.4 Tolerable intakes, allowable concentrations and other quantitative decision criteria |
| | 5.4.1 Basis and definition of TDIs and other measures of tolerable human intakes |
| | 5.4.2 Translating TDIs to allowable fish concentrations |
| | 5.4.3 Additional aspects of human health risk criteria |
| | 5.4.4 Ecotoxicological risk criteria |
| | 5.5 Summarizing characterization |
| | Part B: Risk management analysis |
| | 6 Relevant international and regional policies and management procedures |
| | 6.1 Introduction and conceptualization |
| | 6.1.1 Policy contexts and contents |
| | 6.1.2 Policy approaches and principles |
| | 6.1.3 Policy levels and actors |
| | 6.2 International policies on POP's at the global level |
| | 6.3 European Community policies on dioxins and in other relevant areas |
| | 6.3.1 European chemical policies |
| | 6.3.2 European policies on POP's |
| | 6.3.3 European policies on health and food safety |
| | 6.3.4 European fisheries and marine policies |
| | 6.4 Baltic Sea cooperation on dioxins and related substances |
| | 6.5 National policies on dioxins |
| | 6.6 NGO interests in the Baltic Sea fish and dioxin issue |
| | 6.7 Framing the dioxin issue and implications of the multi-forum activities |
| | 7 Management options and measures, and initial evaluation of their potential |
| | 7.1 Defining and evaluating options along event chains and at various levels and scales |
| | 7.2 Measures before dioxin immission to the sea |
| | 7.2.1 Prevention of formation of dioxins and related compounds |
| | 7.2.2 Control of land-based emissions |
| | 7.2.3 Interception of transport to the sea |
| | 7.3 Measures in the sea |
| | 7.3.1 Control of emissions and fluxes in the sea |
| | 7.3.2 Reduction of dioxin pools in the sea |
| | 7.3.3 Biosteering of dioxin accumulation in marine food-chains |
| | 7.4 Measures on dioxin fluxes after removal from the sea (post-sea measures) |
| | 7.4.1 Reducing intakes by food advisories and other means of information steering |
| | 7.4.2 Reducing intakes by regulating fish marketing and by associated product labeling |
| | 7.4.3 Treating dioxin-laden fish and fish products |
| | 7.4.4 Exposure reduction by supplying surrogate diets and protection |
| | 7.4.5 Exposure reduction by increasing excretion through altered general diet |